University of Massachusetts Medical School Faculty Publications


Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice

UMMS Affiliation

Program in Molecular Medicine



Document Type


Medical Subject Headings

Obesity; Gene Silencing; RNA Interference; Adipose Tissue; Macrophages; Glucose Intolerance


Genetics and Genomics | Nutritional and Metabolic Diseases | Physiology


Adipose tissue (AT) inflammation and infiltration by macrophages is associated with insulin resistance and type 2 diabetes in obese humans, offering a potential target for therapeutics. However, whether AT macrophages (ATMs) directly contribute to systemic glucose intolerance has not been determined. The reason is the lack of methods to ablate inflammatory genes expressed in macrophages specifically localized within AT depots, leaving macrophages in other tissues unaffected. Here we report that i.p. administration of siRNA encapsulated by glucan shells in obese mice selectively silences genes in epididymal ATMs, whereas macrophages within lung, spleen, kidney, heart, skeletal muscle, subcutaneous (SubQ) adipose, and liver are not targeted. Such administration of GeRPs to silence the inflammatory cytokines TNF-alpha or osteopontin in epididymal ATMs of obese mice caused significant improvement in glucose tolerance. These data are consistent with the hypothesis that cytokines produced by ATMs can exacerbate whole-body glucose intolerance.

Rights and Permissions

Citation: Proc Natl Acad Sci U S A. 2013 May 14;110(20):8278-83. doi: 10.1073/pnas.1300492110. Link to article on publisher's site

Related Resources

Link to Article in PubMed

PubMed ID